A novel organic non-linear optical material and a device using the same are disclosed. The material hardly makes reversal symmetrical molecular configuration in a bulk state such as a crystal and a thin layer and shows a high non-linear optical effect. A non-linear optical device using the material has an excellent properties. The organic non-linear optical material is comprised of the following compound: ##STR1## wherein R1, R3 and R4 are independently a hydrogen atom, a cyano group, a phenyl group, an amino group, an alkoxy group, an acylamino group, an alkylthio group, an alkyl group, an alkoxycarbonyl group, carbamoyl group or a heterocyclic group, provided that R3 is allowed to link together with R4 to form a ring and R1, R3 and R4 are not hydrogen atom at the same time; R2 is a hydrogen atom, an alkyl group or an acyl group; and said groups represented by R1, R2, R3, R4 and the ring formed by linking the groups represented by R3 and R4 are allowed to have a substituent.

Patent
   5112532
Priority
Jul 30 1988
Filed
Jul 24 1989
Issued
May 12 1992
Expiry
Jul 24 2009
Assg.orig
Entity
Large
21
7
EXPIRED
1. A non-linear optical device in wave-guide form comprising a compound selected from the group consisting of ##STR4##
2. The device of claim 1 wherein said compound has a planar crystal form.
3. The device of claim 1, wherein said device has a fibre form.
4. The device of claim 1, wherein said device has a form in which a single crystal of said compound is surrounded by a cladding material.

This invention relates to an organic non-linear optical material applicable to the generation of the higher harmonic waves and to the parametric amplification of laser beam, and to the like, and further relates to an organic non-linear optical device, employing it.

A non-linear optical effect is strikingly displayed when exposing a material to intensive light such as laser beams. Such effect can be applied to a frequency conversion, an intensity moderation, a switching operation, and so forth. In recent years, many researches and developments have been made for obtaining the materials capable of displaying such a non-linear optical effect so far. Regarding such research and development of the non-linear optical material, "Non-linear Optical Properties of Organic Molecules and Crystals, vol. 1, 2, edited by AT&T, Academic Press Inc. '87", can be referred.

For the frequency conversion and, in particular, for the Second Harmonic Generation (hereinafter abbreviated to SHG) originated from the second-order non-linear optical effect, there have been some indications of the possibility that an organic compound may display extraordinarily higher efficiency than those of the conventionally known inorganic materials such as lithium niobate (LiNbO3), potassium dihydrogenphosphate (KDP), and so forth. Such an indication is found out in, for example, "Organic Non-linear Optical Materials", compiled under the supervision of Masao Kato and Hachiro Nakanishi, published by C.M.C. Company, Japan, 1985.

The optical non-linearity of an organic compound originates from π electrons of molecules, and the second-order non-linear molecular polarizability (β) becomes particularly greater when the above-mentioned compound has both an electron donative group and an electron attractive group.

There are, however, many compounds including, typically, p-nitroaniline which display no SHG at all or a few in their crystalline arrangement, even if they have a great molecular non-linear polarizability. This is because the molecular orientation in the crystals of polar organic compounds are liable to be centrosymmetric in crystalline arrangement.

It is, accordingly, an object of the invention to provide a novel organic non-linear optical material which can hardly be inversely symmetric in a bulk state such as those of crystals, thin films and so forth, and is capable of displaying a high non-linear optical effect and, further, an organic non-linear optical device employing the material.

The above-mentioned object of the invention can be achieved with a non-linear optical material comprised of a compound represented by the following Formula I and a non-linear optical device employed the above-mentioned material.

Formula I ##STR2## wherein R1, R3 and R4 independently a hydrogen atom, a cyano group, a phenyl group, an amino group, an alkoxy group, acylamino group, an alkylthio group, an alkyl group, an alkoxycarbonyl group, a carbamoyl group, or a heterocyclic group, provided that R3 is allowed to link together with R4 to form a ring and R1, R3 and R4 shall not be hydrogen atoms at the same time; R2 is a hydrogen atom, an alkyl group or an acyl group, and the groups represented by R1, R2, R3, R4 and the ring formed by linking the groups represented by R3 and R4 are allowed to have a substituent.

The invention will now be more detailed below.

In the above-given Formula I, amino groups represented by R1, R3 and R4 include, for example, a methylamino group, a dimethylamino group and so forth.

Alkoxy groups represented by R1, R3 and R4 include, for example, a methoxy group, an ethoxy group, and so forth.

Acylamino groups represented by R1, R3 and R4 include, for example, a benzamido group, an acetoamido group, and so forth.

Alkylthio groups represented by R1, R3 and R4 include, for example, a methylthio group, and so forth.

Alkyl groups represented by R1, R3 and R4 include, for example, a methyl group, an ethyl group, and so forth.

Alkoxycarbonyl groups represented by R1, R3 and R4 include, for example, a methyl carboxylate group, and so forth.

Carbamoyl groups represented by R1, R3 and R4 include, for example, a methyl carbamoyl group, a phenylcarbamoyl group, and so forth.

Heterocyclic groups represented by R1, R3 and R4 include, for example, a pyridyl group, a pyrazolyl group, an imidazolyl group, a pyrimidyl group, a furyl group, a thienyl group, and so forth.

The preferable groups represented by R1, R3 and R4 include, for example, a substituted phenyl group.

The preferable rings completed by linking R3 and R4 together include, for example, a benzene ring.

The rings completed by linking R3 and R4 together are allowed to have a substituent.

Alkyl groups represented by R2 include, for example, a methyl group, an ethyl group, and so forth.

Acyl groups represented by R2 include, for example, a benzoyl group, an acetyl group, and so forth.

The preferable ones represented by R2 include, for example, a hydrogen atom.

R1, R2, R3 and R4 are each allowed to have a substituent.

There is no special limitation to the substituents, but they may be selected from the following electron attractive or electron donative substituents.

The above-mentioned electron attractive substituents are those having a Hammett's constant σρ more than zero. They include, for example, nitro groups, cyano groups, alkylsulfonyl groups such as a methylsulfonyl group, a ethylsulfonyl group and so forth, formyl groups, carbamoyl groups such as a methyl carbamoyl group, a phenylcarbamoyl group, and so forth, sulfamoyl groups such as a methylsulfamoyl group, and so forth, oxycarbonyl groups such as a methoxycarbonyl group, an ethoxycarbonyl group, and so forth, dicyanovinyl groups, carboxy groups, and so forth.

Among these, a nitro group, a cyano group, an alkylsulfonyl group, a formyl group and an alkoxycarbonyl group are preferable.

The above-mentioned electron donative substituents are a halogen atom or those having a Hammett's constant σρ less than zero. They include, for example, amino groups such as an amino group, a methylamino group, a dimethylamino group, a L-2-hydroxymethyl-1-pyrrolidinyl group, and so forth, hydroxyl groups, alkoxy groups such as a methoxy group, an ethoxy group, a butoxy group, and so forth, alkyl groups such as a methyl group, an ethyl group, a propyl group, and so forth.

The compounds represented by Formula I preferably include, for example, those having R1 representing a phenyl group substituted with an electron attractive substituent and R4 representing a phenyl group substituted with an electron donative substituent, or those having R1 representing a phenyl group substituted with an electron donative substituent and R4 representing a phenyl group substituted with an electron attractive substituent.

The compounds preferably applicable to the invention will be exemplified below. It is, however, to be understood that the invention shall not be limited thereto. ##STR3##

The imidazole rings of the compounds relating to the invention may usually be synthesized by making use of amidine having RI and bromacetophenone having R3 and R4. For further details, refer to Chemische Berichte, 34, 637 and, idem, 29, 2097, for example.

The other known synthesizing methods are described in, for example, Chemische Berichte, 38, 1531, id. 35, 2630, Annalen der Chemie, 600, 95-108, id. 663, Synthesis, 1978, 6, Journal of Chemical Society, 1957, 4225, and so forth.

The benzimidazole rings of the compounds relating to the invention are usually synthesized through a dehydration reaction of an o-phenylenediamine derivative with a carboxylic acid derivative.

When R2 represents an alkyl group or an acyl group, the imidazole rings may be synthesized by reacting imidazole with the corresponding alkyl halide or an acid chloride in the presence of base, or they may also readily be synthesized by selecting the raw materials for completing a ring.

PAC Synthesis of Exemplified Compound 1

A solution was prepared by dissolving 15 g of 4-aminosalicylic acid and 11 g of phenylenediamine in 150 ml of dioxane, and 20 g of N,N'-dicyclohexylcarbodiimide was dropped into the solution so as to react them for 4 hours at room temperature. Urea and, then, the solvent were removed from the solution. The resulting solution was heated for I hour at 120°C and, then, refined. Yield was 10 g. The total amount thereof was dissolved in 100 ml of acetonitrile and 7 g of benzoyl chloride was added. The resulting solution was refluxed for 3 hours, and the resulting reacted solution was cooled down, so that 13 g of the objective crystals were obtained,

The structure of the crystals were confirmed with an NMR and an FD mass-spectrometer.

PAC Synthesis of Exemplified Compound 6

p-nitrobenzamidine of 10.25 g was suspended in 50 ml of dimethyl formamide and 3.11 g of bromacetophenone was then added to the suspension. The suspension became exothermic and the color thereof was changed into reddish-brown. After the reddish-brown solution was cooled down, water was added. The resulting solid matters deposited were filtrated.

Yield: 2.27 g

The structure of the solid matters were confirmed with an NMR and an FD mass-spectrometer.

Melting point: 231°C

PAC Synthesis of Exemplified Compound 7

o-aminoacetophenone of 6.75 g was dissolved in 60 ml of acetonitrile. Pyridine of 5 ml was added. Benzoyl chloride of benzoyl chloride was dropped in while stirring. After $ hours, the solvents were distilled off under reduced pressure. An extraction was carried out by adding water and ethyl acetate. An organic layer was dehydrated with anhydrous magnesium sulfate and then the solvents were distilled off.

A crystallization deposition was carried out with alcohol. White crystals of o-benzamidobromacetophenone were thereby obtained. Yield: 9.6 g

In place of the bromacetophenone used in Example 2, 4.97 g of o-benzamidobromacetophenone prepared as mentioned above was so used as to be reacted in the same manner as in Example 2, and a recrystallization was carried out with alcohol. Yield: 3.65 g

The structure of the resulting matter was confirmed with an NMR and a FD mass-spectrometer.

Melting point: Not lower than 250°C

The compounds of the invention may be used as a non-linear optical device, when the compounds are in various forms including, for example, a single crystalline form, a powder form, a liquid form, thin films such as Langmuir-Blodgett film, a vacuum-evaporated film and so forth, the other forms in which the compound is blended in polymers or liquid-crystal molecules, and so forth. The compounds of the invention may also be made pendent to a polymer or used as a clathrate compound or an addition product.

When a non-linear optical device is applied to the non-linear optical material of the invention, such device may be in any publicly known waveguide form. As is described in Japanese Patent O.P.I. Publication No. 63-77035/1988, these forms include, for example, a fibre form, a tabular form, and a form in which a single crystal is surrounded by a cladding material.

The non-linear optical devices of the invention may be frequency conversion and modulation of laser beams, i.e., generation of the higher harmonic wave, parametric amplification, intensity modulation, optical switching, and so forth.

Now, the examples will be described below. It is, however, to be understood that the embodiments of the invention shall not be limited thereto.

The compounds of the invention were evaluated for judging the SHG effect, by the well-known powder method. (Refer to S.K. Kurtz and T.T. Perry; J. Appl. Phys., 39, 3798, 1968.)

The following light source was used. A Q-switched Nd:YAG laser (the wavelength is 1064 nm) Model YG660A manufactured by Quantel International, Inc., U.S.A., having a beam diameter of 2 mm, a repetition rate of 10 pps, a pulse width of 10 ns, and a pulse energy of 20 mJ. A powdered sample filled in a glass-cell was exposed to the laser beam. The product SHG light, 532-nm green light, was spectrally separated by means of a filter and a monochrometer, and intensity of which was detected by means of a photomultiplier tube, so as to obtain the intensity of SHG of each sample relative to that of urea which is regarded as a value of 1.

The results thereof are also shown in Table 1, below.

TABLE 1
______________________________________
Compound SHG Intensity Remark
______________________________________
Urea 1 for Standard
Comparative
m-nitroaniline
6 Comparative
Example 1 7 Invention
Example 4 10 Invention
Example 6 15 Invention
Example 7 16 Invention
Example 15 8 Invention
______________________________________

As is apparent from Table 1, it can be found that the compounds of the invention are excellent non-linear optical materials high in SHG intensity.

The same compounds of the invention as those used in Example 1 were crystallized inside a hollow glass fibre so as to make the non-linear optical devices. When the Nd:YAG laser beam was coupled into these devices from the end-face of the fibre.

Morita, Miki, Masukawa, Toyoaki, Nakayama, Noritaka, Ninomiya, Hidetaka

Patent Priority Assignee Title
5333231, May 02 1991 Ricoh Company, LTD Wavelength conversion element
5360582, Jul 15 1991 Minnesota Mining and Manufacturing Company Nonlinear optical materials containing polar disulfone-functionalized molecules
5481636, May 02 1991 Ricoh Company, Ltd. Wavelength conversion element
5616601, Jul 28 1994 G D SEARLE & CO 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
5767142, Mar 20 1996 RETGERS, THE STATE UNIVERSITY OF NEW JERSEY Trisbenzimidazoles useful as topoisomerase I inhibitors
5807874, May 17 1995 Rutgers, The State University of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
5948797, May 17 1995 Rutgers, The State University of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
5981541, Sep 23 1996 Rutgers, The State University of New Jersey Substituted heterocycles as anti-tumor agents
6063801, Feb 12 1998 Rutgers, The State University of New Jersey Heterocyclic topoisomerase poisons
6140328, Dec 12 1997 Rutgers, The State University of New Jersey Heterocyclic cytotoxic agents
6221892, Feb 12 1998 The State of University of New Jersey, Rutgers Heterocyclic topoisomerase poisons
6399642, Feb 12 1998 Rutgers, The State University of New Jersey Benzimidazole topoisomerase poisons
6486167, Dec 12 1997 Rutgers, The State University of New Jersey Heterocyclic cytotoxic agents
6613789, Jul 28 1994 G. D. Searle & Co. Heterocyclo-substituted imidazoles for the treatment of inflammation
6667302, Dec 31 1997 Rutgers, The State University of New Jersey Heterocyclic topoisomerase poisons
6740650, Apr 29 2002 Rutgers, The State University of New Jersey Heterocyclic cytotoxic agents
6989387, Aug 09 2002 Rutgers, The State University of New Jersey Nitro and amino substituted topoisomerase agents
6992088, Aug 09 2002 Rutgers, The State University of New Jersey Nitro and amino substituted heterocycles as topoisomerase I targeting agents
6992089, Aug 09 2002 Rutgers, The State University of New Jersey Nitro and amino substituted topoisomerase agents
6995154, Dec 31 1997 Rutgers, The State University of New Jersey Heterocyclic topoisomerase poisons
7220770, Jul 28 1994 Heterocyclo-substituted imidazoles for the treatment of inflammation
Patent Priority Assignee Title
4830447, Feb 13 1987 FUJIFILM Corporation Optical wavelength conversion device
4876688, Aug 15 1988 UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE DEPARTMENT OF ENERGY Frequency doubling crystals
4981613, Nov 04 1986 FUJIFILM Corporation Laser light source
4982112, Mar 11 1986 FUJIFILM Corporation Nonlinear optical material
4994209, Aug 21 1987 FUJIFILM Corporation Nonlinear optical material
5016958, Feb 07 1989 E. I. du Pont de Nemours and Company Optical switch having a phase change region therein
DE3707835,
/////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jul 03 1989NINOMIYA, HIDETAKAKONICA CORPORATION A CORP OF JAPANASSIGNMENT OF ASSIGNORS INTEREST 0051090356 pdf
Jul 03 1989NAKAYAMA, NORITAKAKONICA CORPORATION A CORP OF JAPANASSIGNMENT OF ASSIGNORS INTEREST 0051090356 pdf
Jul 03 1989MASUKAWA, TOYOAKIKONICA CORPORATION A CORP OF JAPANASSIGNMENT OF ASSIGNORS INTEREST 0051090356 pdf
Jul 03 1989MORITA, MIKIKONICA CORPORATION A CORP OF JAPANASSIGNMENT OF ASSIGNORS INTEREST 0051090356 pdf
Jul 24 1989Konica Corporation(assignment on the face of the patent)
Date Maintenance Fee Events
Sep 26 1995M183: Payment of Maintenance Fee, 4th Year, Large Entity.
Dec 05 1995ASPN: Payor Number Assigned.
Dec 07 1999REM: Maintenance Fee Reminder Mailed.
May 14 2000EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
May 12 19954 years fee payment window open
Nov 12 19956 months grace period start (w surcharge)
May 12 1996patent expiry (for year 4)
May 12 19982 years to revive unintentionally abandoned end. (for year 4)
May 12 19998 years fee payment window open
Nov 12 19996 months grace period start (w surcharge)
May 12 2000patent expiry (for year 8)
May 12 20022 years to revive unintentionally abandoned end. (for year 8)
May 12 200312 years fee payment window open
Nov 12 20036 months grace period start (w surcharge)
May 12 2004patent expiry (for year 12)
May 12 20062 years to revive unintentionally abandoned end. (for year 12)